Le Lézard
Classified in: Health
Subjects: LAW, PET, ANW

Amatheon Animal Health Obtains Temporary Injunction Against Former Employees


MIAMI, July 25, 2018 /PRNewswire/ -- Over the last year, Amatheon Animal Health has encountered recent growth challenges of which our customer environment was impacted. We understand that our service levels have suffered and as such we have implemented a campaign that will be focused on throughout the year to come to ensure a guarantee of service level improvements across the board. However, we are pleased to announce one of the challenges we faced with regard to our Non-Competition lawsuit has now successfully come to an end.

In the recent months, customers have reported that they were contacted by former employees of Amatheon Animal Health (Amatheon) and their new employer, Pharmsource, LLC, in an effort to sell human pharmaceuticals to the veterinary market.  At Amatheon, we pride ourselves on the great reputation we have built fostering strong customer relationships since 2002.  Accordingly, Amatheon was forced to take actions to protect our reputation and prevent our former employees from using our intellectual property and confidential information to compete against Amatheon.  

Please be advised that a Court Order has been issued, prohibiting Yasmine Garcia, Angela Ruiz-Kandler, Kevin Vander Voord, Nemesio Leon, Maykel Fernandez and Pharmsource from engaging in the business of selling and/or distributing pharmaceuticals of any sort anywhere in the U.S. to the animal health industry for a period of 12 months beginning July 11, 2018.

We would like to take this opportunity to say thank you for being a part of our growing business over the years and we look forward to serving you in the years to come. We are very grateful for your continued patronage, as we wouldn't be here without loyal customers like you.

-          Robert DiCrisci, Chairman, CEO

About AMATHEON
Established in 2002, AMATHEON is the leading veterinary supplier of "Cross-Over Medicationstm" in the nation. Its primary focus is to provide every specialty veterinary hospital in the country with a complete product line of brand and generic medications. Fully licensed and bonded to operate as a nationwide human and veterinary pharmaceutical distributor, AMATHEON has increased its controlled substance market share year over year since inception. For more information, visit www.AMATHEON.com.

SOURCE Amatheon Animal Health


These press releases may also interest you

at 06:30
Johnson & Johnson today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases. At the new rate, the indicated dividend...

at 06:30
The Functional Food Ingredients Market was valued at USD 119.2 billion in 2024, showcases a remarkable growth projection, anticipated to escalate to USD 165.8 billion by 2029, indicating a robust compound annual growth rate (CAGR) of 6.8% from 2024...

at 06:30
According to Future Market Insights (FMI), the...

at 06:30
Héma-Québec is proud to announce a new partnership with CIUSSS de l'Estrie?CHUS, CIUSSS de la Mauricie-et-du-Centre-du-Québec and CHU de Québec?Université Laval that will provide the institutions with a local point person specially dedicated to human...

at 06:25
Johnson & Johnson today announced results for first-quarter 2024. "Johnson & Johnson's solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline," said Joaquin Duato, Chairman and Chief Executive...

at 06:20
The new research gives a complete picture of the Chagas Disease: American trypanosomiasis market. It looks at trends in the CD market, including how common it is in different regions, and talks...



News published on and distributed by: